Gossamer Bio, Inc. (GOSS) vs Kalaris Therapeutics Inc (KLRS)
A side-by-side comparison of Gossamer Bio, Inc. and Kalaris Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GOSS
Gossamer Bio, Inc.
$10.64HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
KLRS
Kalaris Therapeutics Inc
$2.83HealthcareDelayed quote: Oct 6, 2026, 12:35 PM EDT
Total return — GOSS vs KLRS
growth of $100 · dividends reinvested · last 8yGOSS -99.3% (-45.8%/yr)KLRS -99.1% (-44.2%/yr)KLRS compounded faster over this window
GOSS KLRS
GOSS vs KLRS: by the numbers
- •GOSS is the larger company ($65M vs $62M market cap).
- •Both run net losses; KLRS's is the smaller (0.00% vs -235.00% net margin).
Metrics side by side
Valuation
| Metric | GOSS | KLRS |
|---|---|---|
| P/S ratio | 1.22 | N/A |
| P/B ratio | N/A | 1.07 |
Profitability
| Metric | GOSS | KLRS |
|---|---|---|
| Gross margin | 99.56% | 0.00% |
| Operating margin | -336.81% | 0.00% |
| Net margin | -235.00% | 0.00% |
| ROE | N/A | -76.75% |
| ROIC | N/A | -52.40% |
Growth (annualized)
| Metric | GOSS | KLRS |
|---|---|---|
| Total return CAGR (5Y) | -59.51% | -81.13% |
Frequently asked
- How have GOSS and KLRS total returns compared?
- Over the past 5 years, GOSS delivered -59.51% and KLRS delivered -81.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.